跳至主要内容
临床试验/NCT03190655
NCT03190655终止不适用

Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings in the Treatment of Partial Thickness Burns

Melva Louisa2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2017年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
6
试验地点
2
主要终点
Wound healing

研究概览

简要总结

Burn injury is the result of an energy transfer that destroys the skin and adjacent tissues. Partial thickness burn wounds are painful and difficult to manage. The aim of burn treatment in partial thickness burns is to promote rapid wound healing, decrease pain, protect wound from infections, minimize scar formation and functional impairment In recent years, there are progressive development of new dressing material with a variety of option for depth adapted wound management. Many wound dressings are available for superficial and partial thickness burns. Hydrogel based wound dressing provides good biocompatibility with the skin and mucosa and promotes hydration of the wound bed.

Aluminaid wound dressings is a hydrogel based wound dressing that is integrated with aluminium that was designed to reduce acute pain in the treatment of superficial and partical thickness burn injuries.

Up to date, no evidence regarding integrated with aluminium sheet in hydrogel based wound dressings for the use in partial thickness burns. Therefore this trials is aimed to evaluate the efficacy and safety of Aluminaid versus Hydrogel for the treatment of partial thickness burns.

详细描述

This is a prospective, randomized, open label, active controlled trial that aim to evaluate the efficacy and safety of Aluminaid versus Hydrogel wound dressings in the treatment of partial thickness burns.

The study is a multi center trial in children and adults of 12 - 65 years old with partial thickness burns.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

盲法说明

The person that assess the degree of epithelization will be presented with photos of the burn conditions and will not be given information of the patient's treatment.

入排标准

年龄范围
12 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults and children of 12 - 65 years old
  • Partial thickness thermal burns of minimally 1% total body surface area (TBSA)
  • Admission of less than 4 hours of burn injury
  • Patients/legal guardian still have the ability to undergo examinations and give written informed consent.

排除标准

  • Total body surface area (TBSA) of more than 20%
  • Burns caused by chemicals, electricity or radiation
  • Superficial and partial thickness burns located on the faces, palms, soles, genitalia, perineum and joint areas
  • Superficial and partial thickness burns with compartment syndrome
  • Superficial and partial thickness burns with a history of life-threatening trauma
  • Had concomitant disease such as diabetes mellitus
  • Signs of infected burns
  • Patients with known allergies to product containing aluminium, hydrogel or a history of contact dermatitis
  • Other conditions which according to the investigator's judgment are not appropriate to be included in the study.
  • Treated with other agents before attend to clinic (oil, tooth paste, betadine, rivanol etc)

研究组 & 干预措施

Aluminaid

Experimental

Treatment group: Aluminaid wound dressing

干预措施: Aluminaid (Device)

Hydrogel

Active Comparator

Hydrogel wound dressing (Trademark: Burnshield)

干预措施: Hydrogel (Device)

结局指标

主要结局

Wound healing

时间窗: Up to 21 days

Wound healing as determine by the time of complete re-epithelization of the study area, in days.

次要结局

  • Adverse events(At the time of admission up to 21 days of follow up)
  • Erythema(at the time of admission up to 30 minutes)
  • Pain score(At the time of admission up to 30 minutes and 1st week of follow up)
  • Bullae(at the time of admission up to 30 minutes)

研究者

发起方
Melva Louisa
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Melva Louisa

Trial Director

Indonesia University

研究点 (2)

Loading locations...

相似试验